Pharmaguy's Insights Into Drug Industry News
185.8K views | +29 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

Drug Overdose Mortality by State

Drug Overdose Mortality by State | Pharmaguy's Insights Into Drug Industry News | Scoop.it

[From STAT Morning Rounds:] Determined to rein in the opioid epidemic, CDC director Dr. Anne Schuchat is introducing a new campaign to raise awareness about prescription drug abuse in America. The ads feature the stories of patients and families impacted by prescription drug overdoses. “A lot of times, [opioids] are prescribed without the patient asking or recognizing the harm,” Schuchat tells STAT. Health officials are trying to encourage patients to talk to their doctors from the get-go when they’re prescribed opioids. “We want the public to be comfortable asking questions. And we don't want it to be too late by the time that you're hooked,” Schuchat says. The videos will be initially be released in four states hit hard by prescription drug overdoses: West Virginia, Rhode Island, Oregon, and Ohio.

 

The agency also updated its data this week on the rate of prescription drug overdose deaths in recent years. Take a look at the shift above —the darker the color, the higher the rate of prescription drug overdose deaths — and find the full data here.

Pharma Guy's insight:

I am ashamed to say that my state - Pennsylvania - ranks number 6 in deaths dues to drug overdoses!

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Public Citizen: Pharma Industry Abuse-Deterrent Opioid Subsidy Won't Curb Overdose Epidemic

A provision tucked into a U.S. House of Representatives bill to address opioid addiction is nothing but an expensive handout to the pharmaceutical industry that will do little to address the epidemic, Public Citizen said in a letter to Congress.

Lawmakers in the conference committee for the Comprehensive Addiction and Recovery Act are scheduled to meet on Wednesday, July 6, for the first time to discuss the bill.

The provision – Section 803 – would give manufacturers of so-called “abuse-deterrent” forms of opioids unnecessary financial incentives under the Medicaid program for their products.

“There is absolutely no need to provide additional incentives to manufacturers to develop new abuse-deterrent pain products. Manufacturers already are heavily promoting abuse-deterrent formulations as the future of opioid pain relief,” said Dr. Michael Carome, director of Public Citizen’s Health Research Group. “Moreover, new abuse-deterrent products do not warrant expensive incentives because they have not yet been proven to substantially reduce the opioid abuse epidemic. If lawmakers are serious about fighting this public health crisis, they will oppose section 803.”

Read the letter.

Pharma Guy's insight:

Meanwhile, under pressure to stop the US epidemic of opioid abuse and related deaths, the Food and Drug Administration launched a plan to toughen warning labels, improve treatment of both addiction and pain, and expand the use of abuse-deterrent medications. For more on that, read "Opioid Epidemic Getting Worse Due to FDA, Which Now Says It Will Change Its Ways"; http://sco.lt/9Mufmj 

more...
No comment yet.